Unternehmen auf Beobachtungsliste setzen
Merck KGaA
ISIN:
DE0006599905
WKN:
659990
Land: Deutschland
·
Primärmarkt: Deutschland
·
EQS NID: 2123844
Levermann Score
24 April 2025 22:45PM
Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
|
EQS-Ad-hoc: Merck KGaA / Key word(s): Takeover Darmstadt, April 24, 2025 – Merck KGaA (“Merck”) reacts to press reports and confirms late-stage discussions with SpringWorks Therapeutics, Inc. on a potential acquisition. The parties are in discussion on the basis of a price of around USD 47 per share. Merck notes that no final decision has been taken and no legally binding agreement has been entered into.
End of inside information Contact Merck KGaA Dr. Gangolf Schrimpf Merck KGaA Frankfurter Straße 250 64293 Darmstadt Germany Phone: +49 6151 729591 Email: gangolf.schrimpf@merckgroup.com Internet: https://www.merckgroup.com/en ISIN: DE0006599905 WKN: 659990 Indices: DAX Stock exchanges: Regulated Market of Frankfurt am Main (Prime Standard); Open Markets of Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart; EUREX derivatives exchange; London, SIX End of Inside Information
24-Apr-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Merck KGaA |
| Frankfurter Str. 250 | |
| 64293 Darmstadt | |
| Germany | |
| Phone: | +49 (0)6151 72 - 2702 |
| E-mail: | insiderregister@merckgroup.com |
| Internet: | https://www.merckgroup.com/de |
| ISIN: | DE0006599905 |
| WKN: | 659990 |
| Indices: | DAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX |
| EQS News ID: | 2123844 |
| End of Announcement | EQS News Service |
|
|
2123844 24-Apr-2025 CET/CEST
